<DOC>
	<DOCNO>NCT00476697</DOCNO>
	<brief_summary>The purpose investigation evaluate effectiveness high-dose UVA1 irradiation treatment fibrosing condition skin , e.g. , keloid ( thick scar growth fibrous tissue ) , scleroderma ( deposit fibrous tissue skin ) acne keloidalis nucha ( keloids back neck hairline ) old burn scar , granuloma annulare similar skin condition . This UVA1 dosing schedule use successfully Germany various skin disease , mention scleroderma .</brief_summary>
	<brief_title>UVA1 Light Scleroderma Similar Conditions</brief_title>
	<detailed_description>Ultraviolet ray sun reach earth surface divide short wavelength , hence high energy , UVB ( 290-320nm ) long wavelength , hence low energy UVA ( 320-400nm ) . The wavelengths light cause sunburn associate skin cancer causation high energy UVB . UVA wavelength divide relatively short wavelength , hence high energy UVA2 ( 320-340nm ) long wavelength , low energy UVA1 ( 340-400nm ) . Phototherapy light box use clinic treatment psoriasis , atopic dermatitis , pruritus , well use tan salon emit UVB UVA wavelength light . The advantage use UVA1 light source treatment skin condition 1 ) lack skin cancer sunburn cause ray ( UVB ) 2 ) consequence , ability treat patient safely longer . Keloid , scleroderma , acne keloidalis nucha , burn scar characterize collagenous thicken skin result superficial deep cutaneous sclerosis . Treatments disable condition inadequate present . Recently , non-controlled study , UVA1 show induce improvement patient scleroderma , granuloma annulare urticaria pigmentosa ( 1-3 ) . The mode action UVA1 treatment completely understood , however , local immuno-modulation appear important ( 4 ) . UVA1 also show stimulate collagenase activity dose dependent manner dermis ( 5,6 ) . We postulate , therefore , UVA1 appropriate dos improve fibrosing skin condition safely collagenase-mediated removal excess dermal collagen . Based result pilot study , formal control clinical investigation plan .</detailed_description>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<mesh_term>Scleroderma , Localized</mesh_term>
	<mesh_term>Granuloma</mesh_term>
	<mesh_term>Keloid</mesh_term>
	<mesh_term>Acne Keloid</mesh_term>
	<mesh_term>Granuloma Annulare</mesh_term>
	<criteria>Age : 1080 year Clinical diagnosis keloid ( hypertrophic scar ) , scleroderma , acne keloidalis nucha , old burn scar , granuloma annulare , related condition associate alter dermal matrix . No disease state physical condition would impair evaluation test site . Willing able receive UVA1 direct protocol , make evaluation visit , follow protocol restriction . Signed , write , witness , informed consent form . Must live within drive distance Ann Arbor , Michigan . History photosensitivity . Pregnant nursing woman . Systemic therapy fibrosing skin condition within 30 day prior study enrollment . Involved investigational study within previous 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>UVA1</keyword>
	<keyword>scleroderma</keyword>
	<keyword>keloid</keyword>
	<keyword>morphea</keyword>
	<keyword>light therapy</keyword>
</DOC>